CINC
CinCor Pharma, Inc. Common Stock
CINC
CINC
Delisted
CINC was delisted on the 23rd of February, 2023.
86 hedge funds and large institutions have $1.21B invested in CinCor Pharma, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 38 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
83% less call options, than puts
Call options by funds: $617K | Put options by funds: $3.69M
Holders
86
Holding in Top 10
5
Calls
$617K
Puts
$3.69M
Top Buyers
| 1 | +$32.4M | |
| 2 | +$26.5M | |
| 3 | +$25.1M | |
| 4 |
5VM
5AM Venture Management
San Francisco,
California
|
+$19.7M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$19.6M |
Top Sellers
| 1 | -$17.9M | |
| 2 | -$13.3M | |
| 3 | -$12.1M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$10.9M |
| 5 |
VP
venBio Partners
San Francisco,
California
|
-$9.28M |